joey: PM send not working. Re #2) As long as feder

joey: PM send not working. Re #2) As long as federal sched 1 applies to cannabis plant, physical Dharmanol can not legally cross state lines in commerce. Cannabinoids, those derived from the plant, are also sched 1. That restriction is irrelevant as SKTO, as licensor, can license collectives in other states to manufacture BB product lines like Dharmanol and T-Hydrocan for  sales in those other states. Re #1) They are in this for the buy-out, imo. With potential blockbuster BB products coming down the pike, very deep pockets required to entice them from their cave.

Mayor laid out the licensing blueprint in 11/05 CC.

"At no point does SK3 or its subsidiaries ever own the medicines.

"We have management contracts in place to provide various managerial services and licenses to collectives that own or manufacture the medicines.

"Our management contracts are a) with retail managed collectives that sell directly to patients and b) with wholesale managed collectives that take the raw material, that contains the medicine, and manufacture it into finished products, licensed in respect to manufacturing and marketing, and then sell these finished products to other dispensaries.

"The wholesale managed collectives pay us a license fee for the intellectual property rights of products and processes for the creation of products such as Dharmanol and Canna-Loz, (which) license includes the right to use the name of the product and the formula for producing it.

"Now, a great deal of time, effort and expertise have gone into developing these production methods so that they result in consistent products.

The beauty behind this whole thing, Darrell, is that we're exploiting these assets as licensors and consultants in the industry."